Back to mobile site

More on TNYA

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+57.1% Growth)
- Ratings (10.0 Score)

Upcoming Events

- Earnings (8/12/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Tenaya Therapeutics (NQ:TNYA)
Delayed: 0.69 -0.01 (1.43%)
Prev. Close $0.70  
Open$0.70 
52 Wk High$ 
52 Wk Low$ 
Day High$0.71 
Day Low$0.68 
P/E N/A  
EPS$ 
Volume1,960,557 


Jun 3, 2026 07:02 AM Tenaya Therapeutics shows positive gene therapy trial results for heart condition
Jun 3, 2026 07:00 AM Tenaya Therapeutics Announces Interim Data from MyPEAK™-1 Showing Treatment of MYBPC3-associated HCM with TN-201 Gene Therapy Resulted in Consistent Signs of Cardiac Remodeling and Reductions in Sym
Jun 2, 2026 04:30 PM Tenaya Therapeutics to present MyPEAK-1 trial data June 3
Jun 2, 2026 04:30 PM Tenaya Therapeutics to Announce New Interim Data from MyPEAK™-1 Phase 1b/2 Trial of TN-201 for Adults with MYBPC3-Associated HCM on Wednesday, June 3, 2026
May 29, 2026 07:30 PM Form 4 Tenaya Therapeutics, For: May 28 Filed by: Williams R Sanders
May 29, 2026 07:29 PM Form 4 Tenaya Therapeutics, For: May 28 Filed by: Walsh Jeffrey T.
May 29, 2026 07:28 PM Form 4 Tenaya Therapeutics, For: May 28 Filed by: Stehman-Breen Catherine
May 29, 2026 07:13 PM Form 4 Tenaya Therapeutics, For: May 28 Filed by: Srivastava Deepak
May 29, 2026 07:10 PM Form 4 Tenaya Therapeutics, For: May 28 Filed by: Parschauer Karah Herdman
May 29, 2026 07:09 PM Form 4 Tenaya Therapeutics, For: May 28 Filed by: Lee June
View All Articles

Entities mentioned with TNYA

View All Entities